Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/134354
Title: SERUM SEROTONIN IN COGNITIVE DECLINE, CEREBROVASCULAR DISEASE AND CEREBRAL ATROPHY
Authors: THONG HWAI KIT
Keywords: Serotonin, Cogntive Decline, Cerebrovascualar Disease, Cerebral Atophy, Dementia, CIND
Issue Date: 16-Aug-2016
Citation: THONG HWAI KIT (2016-08-16). SERUM SEROTONIN IN COGNITIVE DECLINE, CEREBROVASCULAR DISEASE AND CEREBRAL ATROPHY. ScholarBank@NUS Repository.
Abstract: We investigated baseline serotonin levels in the serum of dementia patients (cognitive impairment with no dementia (CIND) and non-cognitively impaired (NCI) subjects; and association of baseline serum serotonin levels with baseline brain atrophy, baseline cerebrovascular disease, and cognitive decline at 1 year follow up (measured by Mini-Mental State Examination) were investigated. We found that high baseline serum serotonin level was associated with higher risk of having MMSE drop ≥3 at 1 year follow up, in CIND subjects only. Similarly, in CIND subjects only, increase in the central atrophy grading was associated with higher risk of having MMSE drop ≥3 at 1 year follow up. High baseline serum serotonin level was also associated with higher risk of having presence of central atrophy and severe central atrophy at baseline. No significant association was found for presence of cerebrovascular disease at baseline with baseline serum serotonin and MMSE drop.
URI: http://scholarbank.nus.edu.sg/handle/10635/134354
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ThongHK.pdf1.42 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

44
checked on Jan 18, 2019

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.